Literature DB >> 12004000

Nitric oxide supplementation ameliorates dextran sulfate sodium-induced colitis in mice.

Azucena Salas1, Meritxell Gironella, Antonio Salas, Antonio Soriano, Miquel Sans, Juan Iovanna, Josep M Piqué, Julián Panés.   

Abstract

Nitric oxide (NO) synthesis is up-regulated in inflammatory bowel disease. However, its role in the pathophysiology of this condition is controversial. The aims of this study were to assess whether nitric oxide administration ameliorates experimental colitis and to determine the possible mechanisms underlying its effects on intestinal inflammation. For this purpose, the NO donor diethylamine NONOate (DETA/NO; 0.01, 0.1, 1, 5, or 10 mg/kg/day), or the DETA moiety, was administered daily to mice with dextran sulfate sodium-induced colitis. Daily body weight and colonic pathologic alterations at Day 10 were determined. Leukocyte endothelial cell interactions in colonic venules were assessed with intravital microscopy, and expression of endothelial cell adhesion molecules was determined using radiolabeled antibodies. IL-12 and IFN-gamma production were measured in intestinal tissue. Colitis induced a significant loss of body weight, reduction of colon length, and increase in colon weight and myeloperoxidase activity. Administration of 1 mg/kg/day DETA/NO significantly attenuated these pathologic changes. The marked increase in leukocyte rolling and adhesion in colonic venules of colitic mice were significantly reduced by administration of 1 mg/kg/day DETA/NO. Development of colitis was associated with a marked increase in endothelial expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Supplementation with NO significantly attenuated the up-regulation of endothelial intercellular adhesion molecule-1 and P-selectin, but not vascular cell adhesion molecule-1, in colonic tissue. NO abrogated the increase in IL-12 and IFN-gamma mRNA expression in the colon of colitic mice. The DETA moiety alone did not have any effect on any of the parameters studied. In conclusion, exogenous NO supplementation significantly ameliorates dextran sulfate sodium-induced colitis. This effect is related to a reduction in leukocyte recruitment and proinflammatory cytokine production.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12004000     DOI: 10.1038/labinvest.3780454

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

1.  Effects of intestinal trefoil, factor on colonic mucosa in experimental colitis of rats.

Authors:  Tian Yang; Kaifang Zou; Wei Qian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 2.  Inorganic nitrite therapy: historical perspective and future directions.

Authors:  Christopher G Kevil; Gopi K Kolluru; Christopher B Pattillo; Tony Giordano
Journal:  Free Radic Biol Med       Date:  2011-05-04       Impact factor: 7.376

3.  Temporal and spatial dependence of inflammatory biomarkers and suppression by fluvastatin in dextran sodium sulfate-induced rat colitis model.

Authors:  Masaharu Oishi; Katsuji Tokuhara; Hirokazu Miki; Yoshito Tanaka; So Yamaki; Masaki Kaibori; Katsuhiko Yoshizawa; Takashi Yuri; Emi Yoshigai; Mikio Nishizawa; Tadayoshi Okumura; A-Hon Kwon
Journal:  Dig Dis Sci       Date:  2014-04-30       Impact factor: 3.199

4.  The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression.

Authors:  Desiree Camuesco; Monica Comalada; M Elena Rodríguez-Cabezas; Ana Nieto; Maria D Lorente; Angel Concha; Antonio Zarzuelo; Julio Gálvez
Journal:  Br J Pharmacol       Date:  2004-11-08       Impact factor: 8.739

Review 5.  Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle.

Authors:  George Kolios; Vassilis Valatas; Stephen G Ward
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

6.  Temporal inhibition of mouse mammary gland cancer metastasis by CORM-A1 and DETA/NO combination therapy.

Authors:  Kseniia Porshneva; Diana Papiernik; Mateusz Psurski; Agnieszka Łupicka-Słowik; Rafał Matkowski; Marcin Ekiert; Marcin Nowak; Joanna Jarosz; Joanna Banach; Magdalena Milczarek; Tomasz M Goszczyński; Marcin Sieńczyk; Joanna Wietrzyk
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

7.  Epicatechin used in the treatment of intestinal inflammatory disease: an analysis by experimental models.

Authors:  Paulo César de Paula Vasconcelos; Leonardo Noboru Seito; Luiz Cláudio Di Stasi; Clélia Akiko Hiruma-Lima; Cláudia Helena Pellizzon
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-30       Impact factor: 2.629

8.  Anti-inflammatory Effect of Oyster Shell Extract in LPS-stimulated Raw 264.7 Cells.

Authors:  Se-Young Lee; Hak-Ju Kim; Ji-Sook Han
Journal:  Prev Nutr Food Sci       Date:  2013-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.